Up-Regulation of Fas and the Costimulatory Molecules B7-1 and B7-2 on Peripheral Lymphocytes in Autoimmune B6/gld Mice

Journal of Immunology

Volumn 159, Issue 8, 1997, Pages 4117-4126

  Weintraub, Jory P ^a   Eisenberg, Robert A ^b   Cohen, Philip L ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; B7 ANTIGEN; CD86 ANTIGEN; CD86 PROTEIN, MOUSE; FAS ANTIGEN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

AGE; ANIMAL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BIOSYNTHESIS; BONE MARROW CELL; C57BL MOUSE; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; LYMPHOPROLIFERATIVE DISEASE; METABOLISM; MOUSE; PERITONEAL CAVITY; PHYSIOLOGY; SPLEEN; UPREGULATION;

AGE FACTORS; ANIMALS; ANTIBODIES; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; BONE MARROW CELLS; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; LYMPHOPROLIFERATIVE DISORDERS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; PERITONEAL CAVITY; SPLEEN; UP-REGULATION;

EID: 0031572575     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Oehm, A., I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J. Dhein, B. C. Trauth, H. Ponstingl, and P. H. Krammer. 1992. Purification and molecular cloning of the Apo-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: sequence identity with Fas antigen. J. Biol. Chem. 267:10709.
2. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16:39.
3. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169.
4. Bellgrau, D., D. Gold, H. Selawry, J. Moore, A. Franzusoff, and R. C. Duke. 1995. A role for CD95 ligand in preventing graft rejection. Nature 377:630.
5. Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189.
6. Suda, T., T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki, K. Nakao, and S. Nagata. 1995. Expression of the Fas ligand in cells of the T cell lineage. J. Immunol. 154:3806.
7. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
8. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
9. Cohen, P. L., and R. A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243.
10. Davignon, J. L., R. C. Budd, R. Ceredig, P. F. Piguet, H. R. MacDonald, J. C. Cerottini, P. Vassalli, and S. Izui. 1985. Functional analysis of T cell subsets from mice bearing the lpr gene. J. Immunol. 135:2423.
11. Igarashi, S., M. Takiguchi, A. Kariyone, and K. Kano. 1988. Phenotypic and functional analyses on T cell subsets in lymph nodes of MRL/Mp-lpr/lpr mice. Int. Arch. Allergy Appl. Immunol. 86:249.
12. Chu, J. L., P. Ramos, A. Rosendorff, J. Nikolic-Zugic, E. Lacy, A. Matsuzawa, and K. B. Elkon, 1995. Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome. J. Exp. Med. 181:393.
13. Watanabe, D., T. Suda, H. Hashimoto, and S. Nagata. 1995. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 14:12.
14. Adachi, M., R. Watanabe-Fukunaga, and S. Nagata. 1993. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA 90:1756.
15. Berke, G., K. A. Sullivan, and D. B. Amos. 1972. Rejection of ascites tumor allografts. I. Isolation, characterization and in vitro reactivity of peritoneal lymphoid effector cells from BALB/c mice immune to EL4 leukosis. J. Exp. Med. 135:1334.
16. Reap, E. A., M. L. Piecyk, A. Oliver, E. S. Sobel, T. Waldschmidt, P. L. Cohen, and R. A. Eisenberg. 1996. Phenotypic abnormalities of splenic and bone marrow B cells in lpr and gld mice. Clin. Immunol. Immunopathol. 78:21.
17. Gross, J. A., E. Callas, and J. P. Allison. 1992. Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 149:380.
18. + double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR. J. Immunol. 151:597.
19. Abney, E. R., M. D. Cooper, J. F. Kearney, A. R. Lawton, and R. M. E. Parkhouse. 1978. Sequential expression of immunoglobulin on developing mouse B lymphocytes: a systematic survey that suggests a model for the generation of immunoglobulin isotype diversity. J. Immunol 120:2041.
20. Ogasawara, J., R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effect of the anti-Fas antibody in mice. Nature 364:806.
21. + thymocytes by the anti-Fas antibody. J. Exp. Med. 181:485.
22. Morse, H. C., III, W. F. Davidson, R. A. Yetter, E. D. Murphy. J. B. Roths, and R. L. Coffman. 1982. Abnormalities induced by the mutant gene lpr: expansion of a unique lymphocyte subset. J. Immunol. 129:2612.
23. - lymphocytes of lpr mice: comparison with normal immature thymocytes. J. Immunol. 138:1959.
24. Herron, L. R., R. A. Eisenberg, E. Roper, V. N. Kakkanaiah, P. L. Cohen, and B. L. Kotzin. 1993. Selection of the T cell receptor repertoire in lpr mice. J. Immunol. 151:3450.
25. Singer, G. G., and A. K. Abbas. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365.
26. Mandik, L., K.-A. T. Nguyen, and S. Erikson. 1995. Fas receptor expression on B-lineage cells. Eur. J. Immunol. 25:3148.
27. Martinez-Valdez, H., C. Guret, O. deBouteiller, I. Fugier, J. Banchereau, and Y.-J. Liu. 1996. Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, p53, and Bax but not the survival gene bcl-2. J. Exp. Med. 183:971.
28. Azuma, M., H. Yssel, J. H. Phillips, H. Spits, and L. L. Lanier. 1993. Functional expression of B7/BB1 on activated T lymphocytes. J. Exp. Med. 177:845.
29. Das, M. R. P., S. S. Zamvil, F. Borriello, H. L. Weiner, A. H. Sharpe, and V. K. Kuchroo. 1995. Reciprocal expression of co-stimulatory molecules, B7-1 and B7-2, on murine T cells following activation. Eur. J. Immunol. 25:207.
30. Valle, A., P. Carrone, H. Yssel, J. Y. Bonnefoy, A. S. Freedman, G. Freeman, L. M. Nadler, and J. Banchereau. 1990. Mab 104, a new monoclonal antibody, recognizes the B7 antigen which is expressed on activated B cells and HTLV-1 transformed T cells. Immunology 69:531.
31. Finck, B. K., P. S. Linsley, and D. Wofsy. 1994. Treatment of murine lupus with CTLA4Ig. Science 265:1225.
32. Nakajima, A., M. Azuma, S. Kodera, S. Nuriya, A. Terashi, S. Hirose, T. Shirai, H Yagita, and K. Okumura. 1995. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule. Eur. J. Immunol. 25: 3060.
33. + T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis. Clin. Exp. Immunol. 106:218.
34. Horowitz, D. A., F. L. Tang, M. M. Stimmler, A. Oki, and J. D. Gray. 1997. Decreased T cell response to anti-CD2 in systemic lupus erythematosus and reversal by anti-CD28. Arthritis Rheum. 40:822.
35. Garcia-Cozar, F. J., I. J. Molina, M. J. Cuadrado, M. Marubayashi, J. Pena, and M. Santamaria. 1996. Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients. Clin. Exp. Immunol. 104:72.
36. Kovacs, B., D. E. Thomas, and G. C. Tsokos. 1996. Elevated in vivo expression of the costimulatory molecule B7-BB1 (CD80) on antigen presenting cells from a patient with SLE. Clin. Exp. Rheumatol. 14:695.
37. Denfield, R. W., P. Kind, R. D. Sontheimer, E. Schopf, and J. C. Simon. 1997. In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus. Arthritis Rheum. 40:814.
38. Boise, L. H., P. J. Noel, and C. B. Thompson. 1995. CD28 and apoptosis. Curr. Opin. Immunol. 7:620.
39. Tivol, E. A., A. N. Schweitzer, and A. H. Sharpe. 1996. Costimulation and autoimmunity. Curr. Opin. Immunol. 8:822.
40. Epstein, F. H. 1996. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl. J. Med. 335:1369.
41. Bluestone, J. A. 1997. Is CTLA-4 a master switch for peripheral T cell tolerance? J. Immunol. 158:1989.
42. Weller, M., K. Frei, P. Groscurth, P. H. Krammer, Y. Yonekawa, and A. Fontana. 1994. Anti-Fas/Apo-1 antibody-mediated apoptosis of cultured human glioma cells: induction and modulation of sensitivity by cytokines. J. Clin. Invest. 94: 954.
43. Suda, T., M. Tanaka, K. Miwa, and S. Nagata. 1996. Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand. J. Immunol. 157:3918.